Metabolic & Cardiometabolic
bariatric surgery causes durable long-term weight loss
In plain terms: Does bariatric surgery produce durable long-term weight loss vs non-surgical care?
Strong support Metabolic & Cardiometabolic
Part of: 🩺 bariatric / metabolic surgery
RefutedContestedStrong support
consensus score 0.90
Yes—surgery yields large weight loss sustained for 10-20yr far exceeding non-surgical care, though partial regain and procedure-dependent durability are real.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
MechanismIn-vitroAnimalObservationalRCTMeta-analysis
How the studies fall
29 support 0 contradict 0 tested null 4 mixed · 33 sources, 26 independent groups
The evidence (33)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Sjostrom 2004 · N Engl J Med | observational | supports | high | SOS: at 10yr surgery group maintained 16.1% weight loss (gastric bypass 25%) vs +1.6% in matched controls. |
| d10-7759-cureus-112549 2026 · Cureus | observational | supports | moderate | Narrative review (PubMed/Google Scholar, 2020-2025) of RCTs, meta-analyses, and observational studies; concludes SG/RYGB produce 'substantial and sustained' weight loss with lower long-term MACE, CAD, stroke, and all-cause mortality vs cons |
| Shalitin S et al 2026 · study_type: observational | observational | supports | moderate | Real-world EHR cohort (Clalit, Israel), 1035 adolescents undergoing BS 2010-2024, median follow-up 5.8 years; BMI declined significantly with maximal reduction at 1-3y and sustained improvement thereafter, plus durable cardiometabolic benef |
| Susmallian S et al 2026 · study_type: observational | observational | mixed | moderate | Prospective cohort, 300 LSG patients, 193 (64.3%) followed to 10 years; BMI fell to 29.15 at 1y but rose to 31.89 at 10y with regain starting after 3 years, though 51.5% still maintained ≥25% EWL. |
| Sjöström 2013 · J Intern Med | observational | supports | high | In the SOS controlled trial, surgical patients maintained 16-18% weight loss at 10-20 years versus ~0% in matched controls. |
| Mingrone 2021 · Lancet | RCT | supports | high | 10yr RCT: surgery maintained substantially greater weight loss than medical therapy across decade. |
| Noel P et al 2026 · study_type: observational | observational | supports | moderate | Narrative review (PubMed/MEDLINE/Cochrane search, not a formal systematic review) synthesizing ≥10-year outcomes across 5 procedures; weighted mean %TWL at 10y ranged 24.4% (SG) to ~40% (BPD-DS); SLEEVEPASS RCT showed RYGB %EWL 51.9% vs SG |
| Salama 2026 · Surg Endosc | observational | supports | moderate | 20-50% of sleeve patients have insufficient weight loss/regain requiring revision—durability is procedure-dependent, not universal. |
| Bocchinfuso S et al 2026 · study_type: observational | observational | supports | low | Single-center retrospective review, 360 reoperative MBS patients (2000-2024); weight recidivism was the most common indication for reoperation, but reoperation was associated with improved perioperative outcomes and durable long-term weight |
| Athanasopoulou M et al 2026 · study_type: meta-analysis | meta-analysis | supports | moderate | PRISMA systematic review, 39 studies/7375 adolescents (33 observational, 3 RCT, 3 clinical trials); RYGB/SG/LAGB all produced sustained weight loss, LAGB least durable, SG less effective for diabetes remission. |
| Courcoulas 2024 · JAMA | RCT | supports | high | Pooled RCT (ARMMS-T2D) 7-12yr: surgery sustained ~19.3% weight loss vs ~10.8% medical at 7yr. |
| Buzga M et al 2026 · study_type: observational | observational | supports | low | Single-arm pilot, n=10, endoscopic magnetic partial jejunal diversion (not conventional bariatric surgery); at 36 months mean TBWL 15.9%, %EWL 43.2%, with sustained HbA1c improvement. |
| Dallal 2026 · Surg Obes Relat Dis | observational | supports | moderate | Long-term gastric bypass cohort: durable weight loss and survival benefit benchmarked vs GLP-1 era expectations. |
| Hamed H et al 2026 · study_type: observational | observational | supports | moderate | Retrospective cohort, 95 SASI bypass patients, 89/95 (93.7%) with 10-year follow-up; mean %EWL 58.6% and diabetic remission sustained in 88% at 10 years, varying by surgical configuration. |
| Kim Y et al 2026 · study_type: observational | observational | supports | moderate | Narrative synthesis (not systematic review) of long-term MBS studies; reports sustained weight reduction and durable metabolic remission (T2DM, hypertension, dyslipidemia) and lower cardiovascular/mortality risk vs conventional care, with R |
| Susmallian S et al 2026 · study_type: observational | observational | mixed | moderate | Retrospective cohort, 60 patients BMI≥60, up to 10y follow-up; mean %TWL declined from 38.0% (≤2y) to 19.4% (>10y), i.e. roughly half the peak loss regained, though metabolic comorbidity remission persisted. |
| Czerwińska A et al 2026 · study_type: observational | observational | supports | moderate | Retrospective multicenter cohort, 89 patients BMI≥50 with ≥10y follow-up (mean 11.1y); 77.5% reached ≥20%TWL, 58.4% reached ≥50%EWL, though revisional surgery for regain more frequent (43.8%) in the highest-BMI group. |
| Nor Hanipah Z et al 2026 · Obesity Surgery | observational | supports | low | Single-center retrospective, adolescents/young adults (n not stated in extract, 2020-2025), mean follow-up 16 months (range 1-48); %TWL 29.4% at 1y, 29.7% at 2y, 32.0% at 3-5y (stable/improving, not regained). |
| Sjostrom 2014 · JAMA | observational | supports | high | SOS long-term: durable weight loss accompanied diabetes remission/complication reduction over up to 18yr follow-up. |
| Galvan JAA et al 2026 · Journal of Multidisciplinary Healthcare | observational | supports | moderate | Retrospective cohort, 180 Malaysian T2DM patients undergoing SG/RYGB, 5-year follow-up; mean BMI fell from 49.3 to 25.3 kg/m2 and HbA1c from 6.37% to 5.62% (GEE p<0.001), with 2.2% complication rate. |
| Parzer 2024 · Obes Facts | observational | supports | moderate | 10yr SOS analysis: subgroup of surgical patients regains weight; durability varies by individual, body-size perception linked to regain. |
| Papadia FS et al 2026 · study_type: observational | observational | supports | high | 50-year cohort of the original 85-patient biliopancreatic diversion series; %TWL rose from 31% at 1y to 39% at >40y, with universal and durable T2DM remission, though at the cost of rising nutritional morbidity (86% by >40y) and elevated al |
| Konttinen 2024 · Int J Obes | observational | supports | moderate | 15yr SOS: sustained surgical weight loss accompanied lasting improvement in obesity-related quality of life. |
| Tan SYT et al 2026 · study_type: observational | observational | supports | low | Prospective cohort, n=184 Asians BMI≥50, follow-up to 24 months; %TWL ~27% at 12mo and ~27% at 24mo (stable, not declining), similar between SG and GB. |
| Zhong W et al 2026 · study_type: observational | observational | supports | low | Retrospective cohort, 26 mild-obesity + 76 higher-BMI matched patients, mean follow-up ~5 years; mild-obesity group achieved lower %TWL (~20% vs 26%) but comparable durable metabolic composite endpoint (30.7% vs 27.6%). |
| Scheen 2005 · Rev Med Liege | observational | supports | moderate | Independent analysis of SOS 10-year data confirmed 16% weight loss maintained in surgery versus +1.6% gain in conventionally treated controls. |
| Rao RS et al 2026 · study_type: observational | observational | supports | low | Single-center cohort, only 8 of enrolled T1DM patients contributed 5-year data on SADI-S; mean BMI fell from 38.6 to 26.4 kg/m2 with sustained HbA1c and insulin-requirement improvement. |
| d10-1002-ags3-70244 2026 · Annals of Gastroenterological Surgery | observational | mixed | moderate | Single-center Japanese cohort, 28 LAGB patients followed 15 years; %EWL rose to 62% at 5y, 64% at 10y, then fell to 59% at 15y with recurrence of diabetes/hypertension/dyslipidemia after 5-10y and 25% requiring reoperation. |
| Papadia FS. 2026 · study_type: observational | observational | mixed | moderate | Critical review of hypoabsorptive procedures with follow-up to 30 years; 5-year data show 40.6% TWL vs 33.8% for RYGB, but cumulative reoperation reaches 37% at 10 years and nutritional complications affect >80% of patients. |
| Gant L et al 2026 · study_type: observational | observational | supports | moderate | Narrative review of recent trials and techniques; concludes MBS 'consistently achieves superior and sustained weight loss compared with nonsurgical strategies' with durable comorbidity resolution and reduced major cardiovascular events. |
| Schauer 2017 · N Engl J Med | RCT | supports | high | STAMPEDE RCT 5yr: surgical arms lost ~19-23% body weight vs ~5% medical, weight loss durable to 5yr. |
| Gosher N et al 2026 · study_type: observational | observational | supports | moderate | National Israeli registry, 460 adolescents, mostly sleeve gastrectomy; %EWL 56.3% at 6mo, peak 70.7% at 2y, 68.5% at 4y with declining follow-up retention. |
| Mendes C et al 2026 · study_type: observational | observational | supports | low | Retrospective cohort, 81 RYGB patients with 5-year follow-up; BMI fell 44.8→27.7 at 1y but rose to 30.6 at 5y, with 57.1% experiencing >5% weight regain from nadir; comorbidity remission remained significant despite regain. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.